Syndax Pharmaceuticals Inc (SNDX)
18.94
-0.04
(-0.21%)
USD |
NASDAQ |
Nov 04, 16:00
18.50
-0.44
(-2.32%)
After-Hours: 20:00
Syndax Pharmaceuticals Market Cap: 1.612B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.612B |
| November 01, 2024 | 1.615B |
| October 31, 2024 | 1.605B |
| October 30, 2024 | 1.610B |
| October 29, 2024 | 1.624B |
| October 28, 2024 | 1.635B |
| October 25, 2024 | 1.596B |
| October 24, 2024 | 1.616B |
| October 23, 2024 | 1.578B |
| October 22, 2024 | 1.630B |
| October 21, 2024 | 1.662B |
| October 18, 2024 | 1.677B |
| October 17, 2024 | 1.693B |
| October 16, 2024 | 1.693B |
| October 15, 2024 | 1.681B |
| October 14, 2024 | 1.687B |
| October 11, 2024 | 1.628B |
| October 10, 2024 | 1.549B |
| October 09, 2024 | 1.559B |
| October 08, 2024 | 1.564B |
| October 07, 2024 | 1.554B |
| October 04, 2024 | 1.602B |
| October 03, 2024 | 1.590B |
| October 02, 2024 | 1.654B |
| October 01, 2024 | 1.693B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.638B |
| September 27, 2024 | 1.607B |
| September 26, 2024 | 1.545B |
| September 25, 2024 | 1.533B |
| September 24, 2024 | 1.556B |
| September 23, 2024 | 1.526B |
| September 20, 2024 | 1.555B |
| September 19, 2024 | 1.585B |
| September 18, 2024 | 1.532B |
| September 17, 2024 | 1.537B |
| September 16, 2024 | 1.549B |
| September 13, 2024 | 1.627B |
| September 12, 2024 | 1.531B |
| September 11, 2024 | 1.559B |
| September 10, 2024 | 1.601B |
| September 09, 2024 | 1.600B |
| September 06, 2024 | 1.625B |
| September 05, 2024 | 1.668B |
| September 04, 2024 | 1.672B |
| September 03, 2024 | 1.748B |
| August 30, 2024 | 1.749B |
| August 29, 2024 | 1.720B |
| August 28, 2024 | 1.758B |
| August 27, 2024 | 1.771B |
| August 26, 2024 | 1.781B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
180.48M
Minimum
Jan 29 2020
2.110B
Maximum
Jul 16 2024
1.112B
Average
1.066B
Median
Market Cap Benchmarks
| Incyte Corp | 14.59B |
| Trevena Inc | 1.441M |
| Bristol-Myers Squibb Co | 112.46B |
| Arcus Biosciences Inc | 1.423B |
| NovaBay Pharmaceuticals Inc | 3.694M |
Market Cap Related Metrics
| PEG Ratio | -0.1433 |
| Price to Book Value | 3.711 |
| Price | 18.94 |
| Earnings Yield | -17.85% |
| PEGY Ratio | -0.1433 |